Amgen (NASDAQ:AMGN) Stock Price Expected to Rise, Royal Bank Of Canada Analyst Says
Amgen (NASDAQ:AMGN – Get Free Report) had its price target upped by research analysts at Royal Bank Of Canada from $335.00 to $360.00 in a research report issued to clients and investors on Wednesday, Marketbeat reports. The brokerage currently has an “outperform” rating on the medical research company’s stock. Royal Bank Of Canada’s price target [...]

.jpeg%3Fauto%3Dwebp%26trim%3D0%252C256%252C0%252C256%26width%3D1200)








